A human antibody that neutralizes 4 different viruses and has the potential to prevent and treat severe lower respiratory tract infections

A publication in the renowned scientific journal Nature describes a unique human monoclonal antibody (MPE8) discovered by the Swiss Biotech company Humabs BioMed SA in collaboration with the Institute for Research in Biomedicine (IRB) which is affiliated to the Universit� della Svizzera Italiana (USI). Humabs, a privately owned spin-off company of the IRB, is focusing on the discovery of next-generation human monoclonal antibodies to treat infectious and inflammatory diseases...